Table 4 Immune-related adverse events in this trial
irAEs | All grades n (%) | Grade 3 n (%) |
|---|---|---|
Any irAE | 14 (30.4%) | 2 (4.3%) |
Elevated alanine aminotransferase | 6 (13.0%) | 0 |
Hypothyroidism | 5 (10.8%) | 0 |
Hyperthyroidism | 4 (8.7%) | 0 |
Rash | 2 (4.3%) | 1 (2.2%) |
Fatigue | 2 (4.3%) | 0 |
Elevated blood glucose | 2 (4.3%) | 0 |
Elevated creatine kinase | 2 (4.3%) | 0 |
Elevated creatine kinase (MB form) | 2 (4.3%) | 0 |
Immune-mediated pneumonitis | 1 (2.2%) | 1 (2.2%) |
Platelet count decreased | 1 (2.2%) | 0 |
